Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008;7(2):204-14.
doi: 10.1007/s12311-008-0025-0.

Magnetic resonance imaging in spinocerebellar ataxias

Affiliations

Magnetic resonance imaging in spinocerebellar ataxias

Susanne Döhlinger et al. Cerebellum. 2008.

Abstract

Magnetic resonance (MR) imaging is widely used to visualize atrophic processes that occur during the pathogenesis of spinocerebellar ataxias (SCAs). T1-weighted images are utilized to rate the atrophy of cerebellar vermis, cerebellar hemispheres, pons and midbrain. Signal changes in the basal ganglia and ponto-cerebellar fibers are evaluated by T2-weighted and proton density-weighted images. However, two-dimensional (2D) images do not allow a reliable quantification of the degree of atrophy. The latter is now possible through the application of three-dimensional (3D) true volumetric methods, which should be used for research purposes. Ideally, these methods should allow automated segmentation of contrast-defined boundaries by using region growing algorithms, which can be applied successfully in structures of the posterior fossa and basal ganglia. Thin slice thickness helps to minimize partial volume effects. Whereas volumetric approaches rely on predetermined anatomical boundaries, voxel-based morphometry has been developed to determine group differences between different types of SCA (cross-sectional studies) or within one SCA entity (longitudinal studies). We will review recent results and how these methods are currently used to (i) separate sporadic and dominantly inherited forms of cerebellar ataxias; (ii) identify specific SCA genotypes; (iii) correlate patho-anatomical changes with SCA disease symptoms or severity; and (iv) visualize and estimate the rate of progression in SCA.

PubMed Disclaimer

References

    1. Neurology. 2006 Jun 13;66(11):1717-20 - PubMed
    1. Ann Neurol. 2001 Aug;50(2):234-9 - PubMed
    1. J Neurol Neurosurg Psychiatry. 1998 Jan;64(1):140-1 - PubMed
    1. Neurology. 2002 Feb 26;58(4):575-80 - PubMed
    1. Lancet Neurol. 2004 May;3(5):291-304 - PubMed

Publication types

LinkOut - more resources